Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $1.681B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ERAS | ERASCA INC | 10,505,550 | $164M | 9.7% | $20.63 | -17.0% | COM | 29479A108 |
| — | TURNING POINT THERAPEUTICS I | 3,025,000 | $144M | 8.6% | $50.13 | — | COM | 90041T108 |
| DSGN | DESIGN THERAPEUTICS INC | 5,440,453 | $116M | 6.9% | $30.63 | -43.9% | COM | 25056L103 |
| — | PROMETHEUS BIOSCIENCES INC | 1,848,024 | $73.07M | 4.3% | $17.46 | — | COM | 74349U108 |
| — | FORMA THERAPEUTICS HLDGS INC | 4,639,995 | $65.98M | 3.9% | $41.85 | — | SHS | 34633R104 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,002,199 | $61.3M | 3.6% | $20.37 | +2.8% | COM | 61225M102 |
| RVMD | REVOLUTION MEDICINES INC | 2,431,852 | $61.21M | 3.6% | $29.60 | -4.8% | COM | 76155X100 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,565,901 | $54.49M | 3.2% | $29.57 | -39.2% | COM | 28036F105 |
| TNGX | TANGO THERAPEUTICS INC | 4,899,185 | $53.15M | 3.2% | $11.99 | +0.3% | COM | 87583X109 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,012,115 | $47.83M | 2.8% | $28.83 | -17.2% | COM | 05370A108 |
| — | VERVE THERAPEUTICS INC | 1,109,224 | $40.9M | 2.4% | $49.89 | — | COM | 92539P101 |
| BEAM | BEAM THERAPEUTICS INC | 500,000 | $39.84M | 2.4% | $73.61 | +16.3% | COM | 07373V105 |
| IMRX | IMMUNEERING CORP | 2,302,626 | $37.23M | 2.2% | $26.82 | -9.2% | CLASS A COM | 45254E107 |
| BCAB | BIOATLA INC | 1,681,115 | $33M | 2.0% | $33.43 | -23.5% | COM | 09077B104 |
| CYTK | CYTOKINETICS INC | 700,000 | $31.91M | 1.9% | $29.44 | +31.1% | COM NEW | 23282W605 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,403,331 | $31.57M | 1.9% | $28.48 | -8.7% | COM | 87650L103 |
| — | RAIN THERAPEUTICS INC | 2,326,660 | $29.97M | 1.8% | $15.13 | — | COM | 75082Q105 |
| APLS | APELLIS PHARMACEUTICALS INC | 625,000 | $29.55M | 1.8% | $18.80 | +109.4% | COM | 03753U106 |
| STOK | STOKE THERAPEUTICS INC | 1,182,362 | $28.36M | 1.7% | $26.85 | -11.1% | COM | 86150R107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,489,894 | $28.04M | 1.7% | $17.92 | — | SPONSORED ADS | 152309100 |
| BBIO | BRIDGEBIO PHARMA INC | 1,668,909 | $27.84M | 1.7% | $27.82 | +52.1% | COM | 10806X102 |
| BMEA | BIOMEA FUSION INC | 3,170,872 | $23.62M | 1.4% | $17.65 | -40.1% | COM | 09077A106 |
| — | AMBRX BIOPHARMA INC | 2,486,386 | $22.45M | 1.3% | $18.92 | — | SPONSORED ADS | 02290A102 |
| — | AEROVATE THERAPEUTICS INC | 1,830,691 | $21.58M | 1.3% | $21.97 | — | COM | 008064107 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,169,871 | $20.31M | 1.2% | $46.89 | -55.8% | COM | 68062P106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 868,550 | $18.96M | 1.1% | $16.47 | +65.6% | COM | 77313F106 |
| — | TALARIS THERAPEUTICS INC | 1,182,545 | $18.08M | 1.1% | $14.20 | — | COM | 87410C104 |
| — | AXONICS INC | 322,240 | $18.05M | 1.1% | $15.11 | — | COM | 05465P101 |
| ALXO | ALX ONCOLOGY HLDGS INC | 762,079 | $16.38M | 1.0% | $42.62 | +1.2% | COM | 00166B105 |
| VTYX | VENTYX BIOSCIENCES INC | 785,303 | $15.13M | 0.9% | $18.95 | 0.0% | COM | 92332V107 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,679,442 | $15.01M | 0.9% | $32.23 | -51.7% | COM | 04683R106 |
| — | PRAXIS PRECISION MEDICINES I | 752,406 | $14.82M | 0.9% | $53.75 | — | COM | 74006W108 |
| — | IGM BIOSCIENCES INC | 500,000 | $14.66M | 0.9% | $57.43 | — | COM | 449585108 |
| — | CHEMOCENTRYX INC | 400,000 | $14.56M | 0.9% | $36.41 | — | COM | 16383L106 |
| GHRS | GH RESEARCH PLC | 608,123 | $14.19M | 0.8% | $20.43 | +7.6% | ORDINARY SHARES | G3855L106 |
| — | ADICET BIO INC | 750,000 | $13.12M | 0.8% | $17.49 | — | COM | 007002108 |
| ACRS | ACLARIS THERAPEUTICS INC | 900,000 | $13.09M | 0.8% | $19.56 | -22.5% | COM | 00461U105 |
| — | ELEVATION ONCOLOGY INC | 1,983,165 | $11.94M | 0.7% | $12.89 | — | COM | 28623U101 |
| TYRA | TYRA BIOSCIENCES INC | 839,932 | $11.61M | 0.7% | $19.11 | +3.9% | COM | 90240B106 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,273,221 | $11.07M | 0.7% | $15.79 | — | COM | 54300N103 |
| — | MIRATI THERAPEUTICS INC | 75,000 | $11M | 0.7% | $66.72 | — | COM | 60468T105 |
| — | VECTIVBIO HLDG AG | 2,216,763 | $10.88M | 0.6% | $11.47 | — | ORD SHS | H9060V101 |
| PHVS | PHARVARIS N V | 689,731 | $9.925M | 0.6% | $31.46 | -50.3% | COM | N69605108 |
| — | ZYMEWORKS INC | 600,000 | $9.834M | 0.6% | $40.29 | — | COM | 98985W102 |
| — | ICOSAVAX INC | 426,393 | $9.756M | 0.6% | $28.70 | — | COM | 45114M109 |
| KROS | KEROS THERAPEUTICS INC | 150,000 | $8.776M | 0.5% | $49.87 | 0.0% | COM | 492327101 |
| — | AKERO THERAPEUTICS INC | 403,787 | $8.54M | 0.5% | $22.77 | — | COM | 00973Y108 |
| PYXS | PYXIS ONCOLOGY INC | 668,854 | $7.117M | 0.4% | $11.45 | 0.0% | COMMON STOCK | 747324101 |
| — | ITEOS THERAPEUTICS INC | 150,000 | $6.984M | 0.4% | $24.67 | — | COM | 46565G104 |
| ASND | ASCENDIS PHARMA A/S | 50,000 | $6.726M | 0.4% | $124.16 | — | SPONSORED ADR | 04351P101 |
| PLRX | PLIANT THERAPEUTICS INC | 482,413 | $6.513M | 0.4% | $26.54 | -40.1% | COM | 729139105 |
| — | ALIGOS THERAPEUTICS INC | 521,257 | $6.187M | 0.4% | $27.21 | — | COM | 01626L105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 300,000 | $5.931M | 0.4% | $18.72 | -0.5% | COM | 92790C104 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,305,095 | $5.755M | 0.3% | $15.09 | -66.5% | COM | 28617K101 |
| — | Y-MABS THERAPEUTICS INC | 300,000 | $4.863M | 0.3% | $31.28 | — | COM | 984241109 |
| CABA | CABALETTA BIO INC | 1,154,424 | $4.375M | 0.3% | $11.85 | -10.0% | COM | 12674W109 |
| MLTX | HELIX ACQUISITION CORP | 430,000 | $4.253M | 0.3% | $11.03 | — | COM CL A | G4444C102 |
| — | HARPOON THERAPEUTICS INC | 540,600 | $4.082M | 0.2% | $9.47 | — | COM | 41358P106 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 100,000 | $3.864M | 0.2% | $43.58 | 0.0% | COM NEW | 15117B202 |
| — | RENOVACOR INC | 500,000 | $3.85M | 0.2% | $9.05 | — | COM | 75989E106 |
| MGTX | MEIRAGTX HLDGS PLC | 150,000 | $3.561M | 0.2% | $19.14 | 0.0% | COM | G59665102 |
| ANAB | ANAPTYSBIO INC | 100,000 | $3.475M | 0.2% | $23.10 | +37.3% | COM | 032724106 |
| — | AKOUOS INC | 394,500 | $3.353M | 0.2% | $21.34 | — | COM | 00973J101 |
| — | MERUS N V | 100,000 | $3.18M | 0.2% | $14.08 | — | COM | N5749R100 |
| — | GALECTO INC | 1,020,238 | $3.091M | 0.2% | $12.30 | — | COM | 36322Q107 |
| — | ASTRIA THERAPEUTICS INC | 552,903 | $2.98M | 0.2% | $8.84 | — | COM | 04635X102 |
| — | PRECISION BIOSCIENCES INC | 346,524 | $2.564M | 0.2% | $17.95 | — | COM | 74019P108 |
| — | GRAPHITE BIO INC | 203,153 | $2.525M | 0.2% | $29.19 | — | COM | 38870X104 |
| GOSS | GOSSAMER BIO INC | 198,382 | $2.244M | 0.1% | $12.02 | -1.2% | COM | 38341P102 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 392,167 | $2.035M | 0.1% | $31.47 | — | SPON ADS | 05280R100 |
| QURE | UNIQURE NV | 50,000 | $1.037M | 0.1% | $60.55 | -52.6% | SHS | N90064101 |
| — | CONNECT BIOPHARMA HLDGS LTD | 200,000 | $1.03M | 0.1% | $18.50 | — | ADS | 207523101 |
| — | SONENDO INC | 149,200 | $859K | 0.1% | $5.76 | — | COM | 835431107 |
| — | ATRECA INC | 273,500 | $829K | 0.0% | $18.84 | — | CL A COM | 04965G109 |
| — | ORCHARD THERAPEUTICS PLC | 256,649 | $339K | 0.0% | $16.35 | — | ADS | 68570P101 |
| — | IMV INC | 234,374 | $289K | 0.0% | $3.05 | — | COM | 44974L103 |
| — | X4 PHARMACEUTICALS INC | 103,980 | $238K | 0.0% | $6.43 | — | COM | 98420X103 |
| — | OUTLOOK THERAPEUTICS INC | 270,698 | $32,000 | 0.0% | $1.01 | — | *W EXP 02/18/202 | 69012T115 |